Cargando…
Mycoplasma pneumoniae infections serve to enhance the risk of subsequently developing severe allergic diseases by chronically abrogating Treg-mediated suppression
Autores principales: | Takahashi, Ryo, Ushigome, Yukiko, Shiohara, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127772/ http://dx.doi.org/10.1186/2045-7022-4-S3-P109 |
Ejemplares similares
-
Patrolling monocytes sensing herpes simplex virus in severe drug eruption
por: Ushigome, Yukiko, et al.
Publicado: (2014) -
Mycoplasma infection as an inhibitory factor for developing DIHS/DRESS
por: Mizukawa, Yoshiko, et al.
Publicado: (2014) -
Immune reconstitution inflammatory syndrome observed in the setting of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS)
por: Kano, Yoko, et al.
Publicado: (2014) -
Autoimmune sequelae in severe drug eruptions
por: Aoyama, Yumi, et al.
Publicado: (2014) -
Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2013)